Skip to main content
Erschienen in: International Journal of Clinical Oncology 6/2010

01.12.2010 | Case Report

A case of metastatic testicular cancer complicated by pulmonary hemorrhage due to choriocarcinoma syndrome

verfasst von: Shuya Kandori, Koji Kawai, Yoshiharu Fukuhara, Akira Joraku, Naoto Miyanaga, Toru Shimazui, Hideyuki Akaza

Erschienen in: International Journal of Clinical Oncology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

A 40-year-old man was referred to our hospital for treatment of metastatic testicular cancer. Computerized tomography revealed multiple lung, liver, and retroperitoneal lymph node metastases. In addition, magnetic resonance imaging revealed multiple brain metastases. Induction chemotherapy with bleomycin, etoposide, and cisplatin was started the day after a high orchiectomy. The pathological diagnosis of the surgical specimen was yolk sac carcinoma. The serum human chorionic gonadotropin (hCG) was markedly increased to 630,000 mIU/ml, which suggested the presence of a choriocarcinoma element at metastatic sites. The patient subsequently suffered respiratory failure due to pulmonary hemorrhage. Intensive supportive care prevented a fatal outcome. Physicians who treat advanced testicular tumors should be aware of the potential complication of acute pulmonary hemorrhage, called choriocarcinoma syndrome, in cases with a high hCG level, which indicates a rapidly progressive and high-volume choriocarcinoma.
Literatur
1.
Zurück zum Zitat Williams SD, Birch R, Einhorn LH et al (1987) Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastin or etoposide. N Engl J Med 316:1435–1440PubMedCrossRef Williams SD, Birch R, Einhorn LH et al (1987) Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastin or etoposide. N Engl J Med 316:1435–1440PubMedCrossRef
2.
Zurück zum Zitat Nichols CR, Catalano PJ, Crawford ED et al (1998) Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study. J Clin Oncol 16:1287–1293PubMed Nichols CR, Catalano PJ, Crawford ED et al (1998) Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study. J Clin Oncol 16:1287–1293PubMed
3.
Zurück zum Zitat Miki T, Mizutani Y, Akaza H et al (2007) Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor. Int J Urol 14:54–59PubMedCrossRef Miki T, Mizutani Y, Akaza H et al (2007) Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor. Int J Urol 14:54–59PubMedCrossRef
4.
Zurück zum Zitat Miki T, Mizutani Y, Nonomura N et al (2002) Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors. Cancer 95:1879–1885PubMedCrossRef Miki T, Mizutani Y, Nonomura N et al (2002) Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors. Cancer 95:1879–1885PubMedCrossRef
5.
Zurück zum Zitat Logothetis CJ (1984) Choriocarcinoma syndrome. Cancer Bull 36:118–120 Logothetis CJ (1984) Choriocarcinoma syndrome. Cancer Bull 36:118–120
6.
Zurück zum Zitat Logothetis CJ, Samuels ML, Selig DE et al (1986) Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients. Am J Med 81:219–227PubMedCrossRef Logothetis CJ, Samuels ML, Selig DE et al (1986) Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients. Am J Med 81:219–227PubMedCrossRef
7.
Zurück zum Zitat Motzer RJ, Bosl GJ (1987) Hemorrhage: a complication of metastatic testicular choriocarcinoma. Urology 30:119–122PubMedCrossRef Motzer RJ, Bosl GJ (1987) Hemorrhage: a complication of metastatic testicular choriocarcinoma. Urology 30:119–122PubMedCrossRef
8.
Zurück zum Zitat McKendrick JJ, Theaker J, Mead GM (1991) Nonseminomatous germ cell tumor with very high serum human chorionic gonadotropin. Cancer 67:684–689PubMedCrossRef McKendrick JJ, Theaker J, Mead GM (1991) Nonseminomatous germ cell tumor with very high serum human chorionic gonadotropin. Cancer 67:684–689PubMedCrossRef
9.
Zurück zum Zitat Tatokoro M, Kawakami S, Sakura M et al (2008) Successful management of life-threatening choriocarcinoma syndrome with rupture of pulmonary metastatic foci causing hemorrhagic shock. Int J Urol 15:263–264PubMedCrossRef Tatokoro M, Kawakami S, Sakura M et al (2008) Successful management of life-threatening choriocarcinoma syndrome with rupture of pulmonary metastatic foci causing hemorrhagic shock. Int J Urol 15:263–264PubMedCrossRef
10.
Zurück zum Zitat Kirch C, Blot F, Fizazi K et al (2003) Acute respiratory distress syndrome after chemotherapy for lung metastases from non-seminomatous germ-cell tumors. Support Care Cancer 11:575–580PubMedCrossRef Kirch C, Blot F, Fizazi K et al (2003) Acute respiratory distress syndrome after chemotherapy for lung metastases from non-seminomatous germ-cell tumors. Support Care Cancer 11:575–580PubMedCrossRef
Metadaten
Titel
A case of metastatic testicular cancer complicated by pulmonary hemorrhage due to choriocarcinoma syndrome
verfasst von
Shuya Kandori
Koji Kawai
Yoshiharu Fukuhara
Akira Joraku
Naoto Miyanaga
Toru Shimazui
Hideyuki Akaza
Publikationsdatum
01.12.2010
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 6/2010
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-010-0092-3

Weitere Artikel der Ausgabe 6/2010

International Journal of Clinical Oncology 6/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.